Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1995-06-07
1996-11-19
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
A61K 9127
Patent
active
055760180
ABSTRACT:
A method for ameliorating a neurological disorder in a human by administration to the cerebrospinal fluid (CSF) of a therapeutic agent in a dispersion system which allows the therapeutic agent to persist in the cerebro-ventricular space.
REFERENCES:
patent: 4078052 (1978-03-01), Papahadjopoulos
patent: 4089801 (1978-05-01), Schneider
patent: 4145410 (1979-05-01), Sears
patent: 4224179 (1980-09-01), Schneider
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4310506 (1982-01-01), Baldeschwieler et al.
patent: 4394372 (1983-07-01), Taylor
patent: 4522803 (1985-06-01), Lenk et al.
patent: 4588578 (1986-05-01), Fountain et al.
patent: 4599227 (1986-07-01), Dees et al.
patent: 4610868 (1986-09-01), Fountain et al.
patent: 4619913 (1986-11-01), Luck et al.
patent: 4752425 (1988-07-01), Martin et al.
patent: 4769250 (1988-09-01), Forssen
patent: 4781871 (1988-11-01), West, III et al.
patent: 4813399 (1989-03-01), Gordon
patent: 4920016 (1990-04-01), Allen et al.
patent: 5000959 (1991-03-01), Iga et al.
patent: 5021200 (1991-06-01), Vanlerberghe et al.
patent: 5077056 (1991-12-01), Bally et al.
patent: 5204112 (1993-04-01), Hope et al.
patent: 5211955 (1993-05-01), Legros et al.
patent: 5225212 (1993-07-01), Martin et al.
Huang, Biochemistry, 8:334-352, 1969, "Studies on Phosphatidylcholine vesicles formation and Physical characteristics."
Bang, M. Mol. Bio., 13-238-252, 1965, "Diffusion of univalent ions across the lamellae of swollen phospholipids."
Szoka, et al., Ann. Rev. Biophys, Bioeng., 9:465-508, 1980, "Comparative properties and methods of preparation of lipid vesicles (liposomes)."
Shakiba, et al., Investigative ophthalmology and visual Science, 34(10):2903 10, 1993 Sep., "Evaluation of retinal toxicity and liposome encapsulation of Anti-CMV Drug 2'-nor-cyclic GMP."
Frucht-Perry, et al., Cornea, 11(5):393-7, 1992 Sep., "Fibrin-enmeshed tobramycin liposomes: single application topical therapy of pseudomonas . . . ".
Assil, et al., Investigative Ophthalmology and Visual Science, 32(13):3216-20 1991 Dec., "Tobramycin liposomes. Single subconjunctival therapy of . . . ".
Assil, et al., Investigative Ophthalmology and Visual Science, 32(11):2891-7, 1991 Oct., Liposome suppression of proliferative vitreoretinopathy. Rabbit..
Turski, et al., Magnetic Resonance in Medicine, 7(2):184-96, 1988 Jun., "Magnetic resonance imaging of rabbit brain after intracarotid injection . . . ".
Skuta, et al., American Journal of Ophthalmology, 103(5): 714-16, 1987, May 15 "Filtering surgery in owl monkeys treated with the antimetabolitc . . . ".
Assil, et al., Archives of Ophthalmology, 105(3):400-3, 1987 Mar., "Multivesicular liposomes. Sustained release of the antimetabolite . . . ".
Barbet, et al., Biochimica et Biophysica Acta, 772(3):347-356, 1984, May 30, "Weat acid-induced release of liposome-encapsulated carboxyfluorescein".
Kim, et al., Biochim. Biophys. Acta, 646:1, 1981, "Preparation of cell-size unilamellar liposomes with high captured volume and defined size . . . ".
Kim, et al., Biochim. Biophys. Acta, 728:339-348, 1983, "Preparation of multivesicular liposomes".
Kim, et al., Biochim. Biophys. Acta, 793:801, 1985, "Preparation of multilamellar vesicles of defined size-distribution by solvent-spherule . . . ".
Kim, et al., Cancer Treat. Rep., 71:705-711, 1987, "Multivesicular liposomes containing cytarabine entrapped in the presence of . . . ".
Kim, et al., Cancer Research, 47:3935-3937, 1987, "Multivesicular Liposomes Containing cytosine arabinoside for slow-release intrathecal therapy."
Kim, et al., Cancer Treat. Rep., 71:447-450, 1987, "Multivesicular liposomes containing cytosine arabinoside for slow-release . . . ".
Bonetti, et al., Cancer Chemotherapy and Pharmacology, In Press, 1993, "An extended-release formulation of methotrexate for subcutaneous . . . ".
Kim, et al., Cancer Res., 53:1596-1598, 1993, "Prolongation of drug action in CSF by encapsulation into multivesicular liposomes."
Kim, et al., Cancer Chemother Pharmacology, 19:307-310, 1987, "Modulation of the peritoneal clearance of liposomal ara-C by blank liposomes."
Roy, et al., Cancer Chemother, Pharm., 28:105-108, 1991, "Multivesicular liposomes containing bleomycin for subcutaneous administration."
Kim, et al., Reg. Cancer Treat., 2:170-173, 1989, "Intratumoral chemotherapy with multivesicular liposomes containing 1-b-D-arabino . . . ".
Kim, et al., J. Inf. Dis., 162:750-752, 1990, "Multivesicular liposomes for CSF delivery of retroviral agent DDC."
Chamberlain, et al., Archives of Neurol, 50(3):261-264, 1993, "Treatment of leptomeningeal metastasis with intraventricular administration of . . . ".
Chatelut, et al., Cancer Them. Pharmacol., 32:179-182, 1993, "A slow-release methotrexate formulation for inrathecal chemotherapy."
Russack, et al., Ann. Neurol., 34:108-112, 1993, "Quantitative cerebrospinal fluid cytology in patients receiving intracavitary chemotherapy."
Kim, et al., J. Clin. Oncol., 11:2186-2193, 1993, "Extended cerebrospinal-fluid cytarabine exposure following intrathecal administration of DTC 101."
Kim, Drugs, 46:618-638, 1993, "Liposomes as carriers of cancer chemotherapy: a review."
Kim, Kim, Kim, Cancer Chemother. Pharmacol., 33:187-190, 1993, "Extended-release formulation of morphine for subcutaneous administration. "
Ishii, Liposome Technology, 1:111-121, 1993, "Production and Size Control of large unilamellar liposomes by emulsification".
Cullis, et al., Phospholipids and Cellular Regulation, 1:65-123, 1985, "Structural properties and functional roles of phospholipids in . . . ".
Howell Stephen B.
Kim Sinil
DepoTech Corporation
Nutter Nathan M.
LandOfFree
Method for treating neurological disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating neurological disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating neurological disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-538959